Lipid-regulating effect of Traditional Chinese Medicine: Mechanisms of actions

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Bei, Wei Jian ^a   Guo, Jiao ^a   Wu, Hai Yun ^b   Cao, Yang ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING LIPID METABOLISM; ANTHRAQUINONE DERIVATIVE; BERBERINE; CHINESE DRUG; CHOLESTEROL ESTER TRANSFER PROTEIN; CURCUMIN; EZETIMIBE; FATTY ACID SYNTHASE; FENOFIBRATE; GARLIC EXTRACT; GINSENG POLYSACCHARIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LIVER X RECEPTOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; OLEANOLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PLANT EXTRACT; POLYPHENOL; SAPONIN; SITOSTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; STIGMASTEROL; UNINDEXED DRUG; URSOLIC ACID; XUEZHIKANG;

ALISMA; ALPINIA OFFICINARUM; ANGELICA; ANTIDIABETIC ACTIVITY; ARTICHOKE; ATHEROGENESIS; CANCER CELL CULTURE; CASSIA; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; COPTIS; CRATAEGUS; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME REGULATION; EUCOMMIACEAE; FAT INTAKE; FATTY ACID SYNTHESIS; FENUGREEK; GENE EXPRESSION; GINSENG; GYNOSTEMMA PENTAPHYLLUM; HEPATOMA CELL; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERLIPIDEMIA; IC 50; INTESTINE ABSORPTION; INTESTINE CARCINOMA; LIGUSTRUM; LIPID ABSORPTION; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LOW DRUG DOSE; NONHUMAN; OBESITY; PANAX NOTOGINSENG; PINEAPPLE; PLANT ROOT; PLANTAGO OVATA; PLEUROTUS ERYNGII; POLYGONUM; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; REVIEW; RHUBARB; RNA TRANSLATION; SALVIA; TALUS; TEA; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; TRIBULUS TERRESTRIS; UPREGULATION;

EID: 84862336951     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/970635     Document Type: Review

References (63)

1. Durrington P., Dyslipidaemia The Lancet 2003 362 9385 717 731 (Pubitemid 37101072)
2. Wu H., Bei J., Guo J., Chinese herbal medicine for treatment of dislipidemia Journal of Geriatric Cardiology 2009 6 2 119 125
3. Cao X. G., Yu G., Ye X. L., Study of the inhibition of cholesterol absorption by Chinese herbal extracts Chinese Traditional Patent Medicine 2009 31 4 616 618
4. Matsui Y., Kobayashi K., Masuda H., Kigoshi H., Akao M., Sakurai H., Kumagai H., Quantitative analysis of saponins in a tea-leaf extract and their antihypercholesterolemic activity Bioscience, Biotechnology and Biochemistry 2009 73 7 1513 1519
5. Lin Y. J., Li J. H., Yang M., Treating hyperlipidemia using traditional Chinese medicine World Science and Technology-Modernization of Traditional Chinese Medicine and Materia Medica 2008 10 1 103 106
6. Li X.-E., Guo B.-J., Effect of protein and anthraquinone glucosides from Cassia Seed on serum lipid of hyperlipidemia rats China Journal of Chinese Materia Medica 2002 27 5 375 376 (Pubitemid 41296093)
7. Davis H. R., Zhu L. J., Hoos L. M., Tetzloff G., Maguire M., Liu J., Yao X., Iyer S. P. N., Lam M. H., Lund E. G., Detmers P. A., Graziano M. P., Altmann S. W., Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis Journal of Biological Chemistry 2004 279 32 33586 33592 (Pubitemid 39063007)
8. Tang W., Ma Y., Jia L., Niemann-pick C1-like 1 is required for an liver X receptor agonist to raise plasma high density lipoprotein cholesterol in mice Arteriosclerosis Thrombusis Vascular Biology 2008 28 3 448 454
9. Wittenburg H., Carey M. C., Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8 Journal of Clinical Investigation 2002 110 5 605 609 (Pubitemid 34988782)
10. Ge L., Wang J., Qi W., Miao H. H., Cao J., Qu Y. X., Li B. L., Song B. L., The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1 Cell Metabolism 2008 7 6 508 519 (Pubitemid 351729203)
11. Lin Y., Vermeer M. A., Trautwein E. A., Triterpenic acids present in hawthorn lower plasma cholesterol by inhibiting intestinal ACAT activity in hamsters Evidence-Based Complementary and Alternative Medicine 2011 2011 9
12. Lin M. C., Wang E. J., Lee C., Chin K. T., Liu D., Chiu J. F., Kung H. F., Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine Journal of Nutrition 2002 132 6 1165 1168 (Pubitemid 34606445)
13. Chang W., Wang H., Yin H. F., Zhou Q. X., Yang J. X., Effects of berberine on cholesterol metabolism and Insig-2 gene expression of hyperlipidemic rats Chinese Pharmacological Bulletin 2009 25 1 85 88
14. Li J., Yu L., Li N., Wang H., Astragalus mongholicus and Angelica sinensis compound alleviates nephrotic hyperlipidemia in rats Chinese Medical Journal 2000 113 4 310 314 (Pubitemid 30241508)
15. Gebhardt R., Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts Journal of Pharmacology and Experimental Therapeutics 1998 286 3 1122 1128 (Pubitemid 29135519)
16. Yi J., Xiaohui L., Ya L., Haigang Z., Atherosclerosis lesion is accelerated by persistent systemic inflammation but attenuated by saponins from Panax Notoginseng in rabbits Journal of Medical Colleges of PLA 2008 23 1 38 44
17. Xiao W. P., Zhang R., Sun Y. H., Enhancement of inhibitory activity of green tea extract on fatty acid synthase by hydrogen ion Chinese Journal of Biochemistry and Molecular Biology 2006 22 3 234 238
18. Wang X., Song K. S., Guo Q. X., Tian W. X., The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase Biochemical Pharmacology 2003 66 10 2039 2047 (Pubitemid 37352867)
19. Mead J. R., Irvine S. A., Ramji D. P., Lipoprotein lipase: structure, function, regulation, and role in disease Journal of Molecular Medicine 2002 80 12 753 769 (Pubitemid 35478124)
20. Perret B., Mabile L., Martinez L., Tercé F., Barbaras R., Collet X., Hepatic lipase: structure/function relationship, synthesis, and regulation Journal of Lipid Research 2002 43 8 1163 1169 (Pubitemid 34988164)
21. Nakamura T., Kugiyama K., Triglycerides and remnant particles as risk factors for coronary artery disease Current Atherosclerosis Reports 2006 8 2 107 110
22. Niho N., Mutoh M., Takahashi M., Tsutsumi K., Sugimura T., Wakabayashi K., Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2970 2974 (Pubitemid 40299900)
23. Gao Q. Y., Chen S. M., Effect of berberine on the expression of oxLDL, LPL in alveolar and peritoneal macrophages in diabetic rats Chinese Journal of Cardiovascular Medicine 2008 13 277 279
24. Zhang Z., Ho W. K. K., Huang Y., Chen Z. Y., Hypocholesterolemic activity of hawthorn fruit is mediated by regulation of cholesterol-7 -hydroxylase and acyl CoA: cholesterol acyltransferase Food Research International 2002 35 9 885 891 (Pubitemid 35224866)
25. Manjunatha H., Srinivasan K., Hypolipidemic and antioxidant effects of dietary curcumin and capsaicin in induced hypercholesterolemic rats Lipids 2007 42 12 1133 1142 (Pubitemid 350303595)
26. Jang E. M., Choi M. S., Jung U. J., Kim M. J., Kim H. J., Jeon S. M., Shin S. K., Seong C. N., Lee M. K., Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters Metabolism 2008 57 11 1576 1583
27. McGovern P. E., Zhang J., Tang J., Zhang Z., Hall G. R., Moreau R. A., Nuez A., Butrym E. D., Richards M. P., Wang C. S., Cheng G., Zhao Z., Wang C., Fermented beverages of pre- and proto-historic China Proceedings of the National Academy of Sciences of the United States of America 2004 101 51 17593 17598 (Pubitemid 40051931)
28. Kwak Y. S., Kyung J. S., Kim J. S., Cho J. Y., Rhee M. H., Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng Biological and Pharmaceutical Bulletin 2010 33 3 468 472
29. Zambon A., Deeb S. S., Pauletto P., Crepaldi G., Brunzell J. D., Hepatic lipase: a marker for cardiovascular disease risk and response to therapy Current Opinion in Lipidology 2003 14 2 179 189 (Pubitemid 36521189)
30. Jansen H., Verhoeven A. J. M., Sijbrands E. J. G., Hepatic lipase: a pro- or anti-atherogenic protein? Journal of Lipid Research 2002 43 9 1352 1362
31. Li J. G., Qu W. J., Wei S. Q., Effect of tribu saponin from Tribulus terrestris on the lipoprotein lipase and (hepatic) lipase activity in lipid metabolic disorder mice Chinese Traditional Patent Medicine 2007 29 6 808 811
32. Guo J., Bei W. J., Tang C. P., The effect of fufang zhenshu tiaozhi extract on hepatic lipase in diet-induced hyperlipidemic rats Zhong Yao Cai 2009 32 582 585
33. Mizutani T., Inatomi S., Inazu A., Kawahara E., Hypolipidemic effect of Pleurotus eryngii extract in fat-loaded mice Journal of Nutritional Science and Vitaminology 2010 56 1 48 53
34. Shin J. E., Myung J. H., Kim D. H., 3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase Biological and Pharmaceutical Bulletin 2003 26 6 854 857 (Pubitemid 39655308)
35. Xie W., Wang W., Su H., Xing D., Cai G., Du L., Hypolipidemic mechanisms of Ananas comosus L. leaves in mice: different from fibrates but similar to statins Journal of Pharmacological Sciences 2007 103 3 267 274 (Pubitemid 46465769)
36. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., Jiang J. D., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Nature Medicine 2004 10 12 1344 1351 (Pubitemid 40022716)
37. Pan W. N., Wang S. K., Wang Z. Z., Hydrochloric effect on Berberine effects on human liver cell line Bel-7402 expression of LDLR Journal of Nanjing Medical University 2005 25 12 865
38. Abidi P., Zhou Y., Jiang J. D., Liu J., Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 10 2170 2176 (Pubitemid 41416317)
39. Lin X. H., Xu W. R., Liu P., The hyperlipidemic study of dihydrotanshinone I Zhong Cao Yao 2008 39 1378 1380
40. Xue J., Xie M. L., Guo Z. L., Effects of serum-drug of Radix Salviae Miltiorrhizae and Fructus Crataegi extracts on cholesterolmetabolism Zhong Cao Yao 2007 38 1 73 77 (Pubitemid 46359234)
41. Ji W., Gong B. Q., Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats Journal of Ethnopharmacology 2008 119 2 291 298
42. Vijayakumar M. V., Pandey V., Mishra G. C., Bhat M. K., Hypolipidemic effect of fenugreek seeds is mediated through inhibition of fat accumulation and upregulation of LDL receptor Obesity 2010 18 4 667 674
43. Huang T. H. W., Tran V. H., Roufogalis B. D., Li Y., Gypenoside XLIX, a naturally occurring PPAR- activator, inhibits cytokine-induced vascular cell adhesion molecule-1 expression and activity in human endothelial cells European Journal of Pharmacology 2007 565 1-3 158 165 (Pubitemid 46782788)
44. Burris T. P., Montrose C., Houck K. A., Osborne H. E., Bocchinfuso W. P., Yaden B. C., Cheng C. C., Zink R. W., Barr R. J., Hepler C. D., Krishnan V., Bullock H. A., Burris L. L., Galvin R. J., Bramlett K., Stayrook K. R., The hypolipidemic natural product guggulsterone is a promiscuous steroid receptor ligand Molecular Pharmacology 2005 67 3 948 954 (Pubitemid 40365342)
45. Yoon M., Lee H., Jeong S., Kim J. J., Nicol C. J., Nam K. W., Kim M., Cho B. G., Oh G. T., Peroxisome proliferator-activated receptor is involved in the regulation of lipid metabolism by ginseng British Journal of Pharmacology 2003 138 7 1295 1302 (Pubitemid 36543127)
46. Garcia-Diez F., Garcia-Mediavilla V., Bayon J. E., Gonzalez-Gallego J., Pectin feeding influences fecal bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats Journal of Nutrition 1996 126 7 1766 1771 (Pubitemid 26231442)
47. Vergara-Jimenez M., Conde K., Erickson S. K., Fernandez M. L., Hypolipidemic mechanisms of pectin and psyllium in guinea pigs fed high fat-sucrose diets: alterations on hepatic cholesterol metabolism Journal of Lipid Research 1998 39 7 1455 1465 (Pubitemid 28332480)
48. Romero A. L., West K. L., Zern T., Fernandez M. L., The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs Journal of Nutrition 2002 132 6 1194 1198 (Pubitemid 34606451)
49. Guo J., Bei W., Hu Y., Tang C., He W., Liu X., Huang L., Cao Y., Hu X., Zhong X., Cao L., A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats Journal of Ethnopharmacology 2011 135 2 299 307
50. Shi L. Y., Tian M., Chang W., Yuan Y., Zhou Q. X., Effect of Berberine on the expression of lipid metabolism-associated gene PPAR and CPTIA Chinese Pharmacological Bulletin 2008 24 11 1461 1464
51. Gao D., Li Q., Li Y., Liu Z., Liu Z., Fan Y., Han Z., Li J., Li K., Antidiabetic potential of oleanolic acid from Ligustrum lucidum Ait Canadian Journal of Physiology and Pharmacology 2007 85 11 1076 1083 (Pubitemid 351196406)
52. Park C. H., Yamabe N., Noh J. S., Kang K. S., Tanaka T., Yokozawa T., The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice Biological and Pharmaceutical Bulletin 2009 32 10 1734 1740
53. Chawla A., Saez E., Evans R. M., Don't know much bile-ology Cell 2000 103 1 1 4
54. Chiang J. Y. L., Bile acids: regulation of synthesis Journal of Lipid Research 2009 50 10 1955 1966
55. Berger J., Moller D. E., The mechanisms of action of PPARs Annual Review of Medicine 2002 53 409 435 (Pubitemid 34177889)
56. Staels B., Fruchart J. C., Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 2005 54 8 2460 2470 (Pubitemid 41134276)
57. Brown M. S., Goldstein J. L., The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 1997 89 3 331 340 (Pubitemid 27220877)
58. Horton J. D., Goldstein J. L., Brown M. S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver Journal of Clinical Investigation 2002 109 9 1125 1131 (Pubitemid 34496588)
59. Edwards P. A., Kast H. R., Anisfeld A. M., BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis Journal of Lipid Research 2002 43 1 2 12 (Pubitemid 34117211)
60. Raghow R., Yellaturu C., Deng X., Park E. A., Elam M. B., SREBPs: the crossroads of physiological and pathological lipid homeostasis Trends in Endocrinology and Metabolism 2008 19 2 65 73 (Pubitemid 351317897)
61. Repa J. J., Liang G., Ou J., Bashmakov Y., Lobaccaro J. M. A., Shimomura I., Shan B., Brown M. S., Goldstein J. L., Mangelsdorf D. J., Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR and LXR Genes and Development 2000 14 22 2819 2830
62. Joseph S. B., Laffitte B. A., Patel P. H., Watson M. A., Matsukuma K. E., Walczak R., Collins J. L., Osborne T. F., Tontonoz P., Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors Journal of Biological Chemistry 2002 277 13 11019 11025 (Pubitemid 34952859)
63. Urizar N. L., Liverman A. B., Dodds D. T., Silva F. V., Ordentlich P., Yan Y., Gonzalez F. J., Heyman R. A., Mangelsdorf D. J., Moore D. D., A natural product that lowers cholesterol as an antagonist ligand for FXR Science 2002 296 5573 1703 1706 (Pubitemid 34579172)